Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Biogen, Eisai, Hemex, Krystal, Median Technologies, Peijia, Sanofi.

Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: BD, CSL, Memo, Vesalic, Waters.

Clinical updates for biopharma and med tech, including data readouts and publications: Anixa, Atraverse, Biofrontera, Breye, Cala, Clearmind, Estrella, Johnson & Johnson, Lumosa, Rapid, Roche, Zenas.

Biopharma and med-tech companies raising money in public or private financings, including: Aerska, Ascletis, Ernexa, Quantx.

Clinical updates for biopharma and med tech in Asia-Pacific, including data readouts and publications: Hoya Vision Care, Olympus.

New hires and promotions in the biopharma and med-tech industries in Asia-Pacific, including: United Imaging Healthcare.

Biopharma and med-tech companies in Asia-Pacific raising money in public or private financings: Adlai Nortye.

Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Akeso, Astrazeneca, Daiichi Sankyo, Everest Medicines, Kelun-Biotech, Neurophet.

Biopharma and med-tech happenings in Asia-Pacific, including deals and partnerships, and other news in brief: 48Hour Discovery, Advancell, Arctic Vision, Biodexa, Biomica, Eisai, Eli Lilly, Everest Medicines,  Evogene, Golden Age Health, Henlius, Lishan, MDCO Technology, Micot, Newsoara, Otsuka, Phase Scientific, Tenacia, Vtv, Zonsen Peplib.